Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersHematology & Oncology Physician in Noblesville, IN
NPI: 1205896818Primary Practice Location
RIVERVIEW HEALTH
395 Westfield Rd, Noblesville, IN
Primary Employer
Zangmeister Cancer Center
zangcenter.com
HQ Phone
Get M.D. Daniel's Phone Numberphone_androidMobile
Get M.D. Daniel's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIN State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 506 | 704 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 451 | 904 |
| 3 | 85025Complete blood cell count (red cells, white blood cell, platelets), automated test | 353 | 918 |
| 4 | 36415Insertion of needle into vein for collection of blood sample | 155 | 276 |
| 5 | 99205New patient office or other outpatient visit, typically 60 minutes | 144 | 144 |
American Society of Clinical Oncology provisional clinical opinion: epidermal growth factor receptor (EGFR) Mutation testing for patients with advanced non-small-cell lung cancer considering first-line EGFR tyrosine kinase inhibitor therapy.
Authors: Vicki Keedy
Publication Date: 2011-04-13
Authors: Karl Lewis, Tawnya Bowles, Jose Lutzky, Mohammed Milhem, Suprith Badarinath, Sujith Kalmadi, Eddy Hsueh, Jeffrey Travers, Suthee Rapisuwon, Brian Gastman, Pallavi Kumar, Vinay Gupta, Prejesh Philips, Anna Bar, Juan Paramo, Brendan Curti, Robert Weber, Craig Slingluff, Montaser Shaheen, Peter Beitsch, John Glaspy, Edward Levine, Deepti Behl, Svetomir Markovic, Sajeve Thomas, Omid Hamid, Takami Sato, J Beck, Robert Andtbacka, Arvinda Padmanabhan
Journal: J Immunother Cancer
Lead Sponsor: Exact Sciences Corporation
Intervention / Treatment: OTHER: Blood Sample Collection
Lead Sponsor: ECOG-ACRIN Cancer Research Group
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, OTHER: Clinical Observation, DRUG: Crizotinib
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, OTHER: Clinical Observation, OTHER: Placebo Administration, DRUG: Erlotinib Hydrochloride
